CYTOKINETICS INC (CYTK) Stock Income Statement
NASDAQ:CYTK - Nasdaq - US23282W6057 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 18.47M | 7.53M | 94.60M | 70.40M | 55.80M | |||
| Operating Expenses | 554.72M | 503.74M | 418.80M | 256.70M | 149.80M | |||
| Research and Development | 339.41M | 330.12M | 240.80M | 159.90M | 97.00M | |||
| Selling, General, and Administrative Expenses | 215.31M | 173.61M | 178.00M | 96.80M | 52.80M | |||
| Operating Income | -536.25M | -496.20M | -324.20M | -186.30M | -93.90M | |||
| Interest Income/Expense | -33.68M | -30.04M | -39.80M | -29.00M | -33.30M | |||
| Other Income/Expense | -19.60M | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | 0.00 | 0.00 | -24.90M | N/A | N/A | |||
| Income Before Taxes | -589.53M | -526.24M | -389.00M | -215.30M | -127.30M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -589.53M | -526.24M | -389.00M | -215.30M | -127.30M | |||
| EBITDA | -526.72M | -484.31M | -318.39M | -184.02M | -92.07M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.26 | -5.45 | -4.33 | -2.80 | -1.97 | |||
| Non GAAP EPS | -5.26 | -5.45 | -4.22 | -2.83 | -2.01 | |||
| Statistics | ||||||||
| Profit Margin | -3191.11% | -6988.63% | -411.21% | -305.82% | -228.14% | |||
| Operating Profit Margin | -2902.72% | -6589.71% | -342.71% | -264.63% | -168.28% | |||
All data in USD